Skip to Content
Merck

Trichloroethylene and Parkinson disease.

Neurologic clinics (2011-08-02)
Fariha Zaheer, John T Slevin
ABSTRACT

Multiple genetic and environmental etiologies have been implicated in the pathogenesis of idiopathic Parkinson disease. Recent observations have suggested an association between chronic exposure to trichloroethylene (TCE) and development of clinical parkinsonism. Animal models of TCE exposure have shown nigrostriatal degeneration and the development of parkinsonian features. Animal and cell culture models indicate mitochondrial dysfunction as the probable mechanism, most likely mediated by TaClo, a potential TCE metabolite. These observations endorse the hypothesis that a variety of environmental risk factors may cause nigrostriatal degeneration and clinical parkinsonism in genetically predisposed individuals.

MATERIALS
Product Number
Brand
Product Description

Supelco
Trichloroethylene solution, certified reference material, 5000 μg/mL in methanol
Sigma-Aldrich
Trichloroethylene, anhydrous, contains 40 ppm diisopropylamine as stabilizer, ≥99%
Supelco
Trichloroethylene, analytical standard, stabilized with 30 – 50 ppm Diisopropylamine
Sigma-Aldrich
Trichloroethylene, ACS reagent, ≥99.5%
USP
Residual Solvent Class 2 - Trichloroethylene, United States Pharmacopeia (USP) Reference Standard